Your browser doesn't support javascript.
loading
Multiple DNA Viruses and HPV Integration in Inverted Papilloma and Associated Sinonasal Carcinoma.
Jauhiainen, Maria K; Pyöriä, Lari; Viitasalo, Sanna; Aaltonen, Leena-Maija; Söderlund-Venermo, Maria; Hagström, Jaana; Mäkitie, Antti A; Perdomo, Maria F; Sinkkonen, Saku T.
Affiliation
  • Jauhiainen MK; Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Pyöriä L; Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Viitasalo S; Research Program in Systems Oncology, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Aaltonen LM; The Doctoral Programme in Clinical Research, Faculty of Medicine, University of Helsinki, Helsinki, Finland.
  • Söderlund-Venermo M; Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Hagström J; Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Mäkitie AA; Department of Otorhinolaryngology - Head and Neck Surgery, Helsinki University Hospital and University of Helsinki, Helsinki, Finland.
  • Perdomo MF; Department of Virology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Sinkkonen ST; Department of Pathology, University Hospital of Helsinki, Helsinki, Finland.
Laryngoscope ; 2024 Aug 22.
Article in En | MEDLINE | ID: mdl-39171991
ABSTRACT

OBJECTIVES:

Sinonasal inverted papilloma (IP) has a locally destructive growth pattern, can relapse, and can undergo malignant transformation (IP-associated sinonasal squamous cell carcinoma (IP-SNSCC)). Human papillomaviruses (HPV)-6 and -16 are frequently detected in IPs. To clarify the possible roles of other DNA viruses in IPs, we explored viruses not studied in this context before. With the setting of pre- and post-malignant transformation samples, we investigated HPV genomes in depth to assess the integration of HPV into the human genome and the presence of minor intratypic variants. MATERIALS AND

METHODS:

We analyzed 35 IP samples representing 28 individuals, of which six had IP-SNSCC. For virus screening, we applied qPCR to detect 16 different DNA viruses in three virus families, comprising herpesviruses, parvoviruses, and polyomaviruses. In addition, targeted next generation sequencing (NGS) was used for detailed HPV analysis.

RESULTS:

We detected herpes-, parvo-, and polyomaviruses in 13/28 (46%) patients, with codetections of multiple viruses in six (21%) patients. NGS revealed HPV16 DNA in 2/6 IP-SNSCC and in their respective earlier benign IP samples, as well as in a plasma sample from one of these patients. HPV6 was detected in two IP samples without subsequent malignant transformation. We identified sequence reads containing junctions of HPV6 and HPV16 and host genome suggestive of viral integration. HPV6 and HPV16 minor intratypic variants were present across pre- and post-malignant transformation, with mostly nonsynonymous mutations.

CONCLUSIONS:

Multiple DNA viruses were present in IPs. HPV16 was detected only in IP-SNSCCs or in tumors that later underwent malignant transformation. LEVEL OF EVIDENCE 3 Laryngoscope, 2024.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Laryngoscope Journal subject: OTORRINOLARINGOLOGIA Year: 2024 Document type: Article Affiliation country: Finland Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Laryngoscope Journal subject: OTORRINOLARINGOLOGIA Year: 2024 Document type: Article Affiliation country: Finland Country of publication: United States